Elisabeth Hulier-Ammar , Amélie Chioccarello , Pauline Touche , Achille Ivasilevitch , Henri-Corto Stoeklé , Christian Hervé
{"title":"Recherche sur données : aspects juridiques et éthiques à travers l’expérience de l’hôpital Foch","authors":"Elisabeth Hulier-Ammar , Amélie Chioccarello , Pauline Touche , Achille Ivasilevitch , Henri-Corto Stoeklé , Christian Hervé","doi":"10.1016/j.meddro.2021.06.003","DOIUrl":null,"url":null,"abstract":"<div><p>Health data is the object of covetousness by many actors, of course by the healthcare industry, in particular the drug and medical device industry, by hospitals and research institutes, but also by all types of merchant companies which would like to derive substantial benefits from it. Faced with this phenomenon, the European Commission, within the framework of the replacement of the European Directive on health data of 1995, by the General Data Protection Regulation of 2016 (GDPR) has strengthened the protection of health data which is particularly sensitive data for everyone and, consequently, carrying out studies on health data. Researches that does not involve human beings, improperly called “Data studies”, are closely regulated by the GDPR and, for France, by the Data Protection Act, which has been amended accordingly. This article describes the steps to be taken for the implementation of data studies and what are the rights of participants/patients in the context of these researchs. Ethical vigilance would require that such research be reviewed by an ad hoc committee.</p></div>","PeriodicalId":41275,"journal":{"name":"Medecine & Droit","volume":"2022 172","pages":"Pages 8-14"},"PeriodicalIF":0.1000,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.meddro.2021.06.003","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medecine & Droit","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1246739121000622","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, LEGAL","Score":null,"Total":0}
引用次数: 2
Abstract
Health data is the object of covetousness by many actors, of course by the healthcare industry, in particular the drug and medical device industry, by hospitals and research institutes, but also by all types of merchant companies which would like to derive substantial benefits from it. Faced with this phenomenon, the European Commission, within the framework of the replacement of the European Directive on health data of 1995, by the General Data Protection Regulation of 2016 (GDPR) has strengthened the protection of health data which is particularly sensitive data for everyone and, consequently, carrying out studies on health data. Researches that does not involve human beings, improperly called “Data studies”, are closely regulated by the GDPR and, for France, by the Data Protection Act, which has been amended accordingly. This article describes the steps to be taken for the implementation of data studies and what are the rights of participants/patients in the context of these researchs. Ethical vigilance would require that such research be reviewed by an ad hoc committee.
期刊介绍:
The Scientific Committee of the journal Médecine et Droit includes professors of medicine, professors of law, magistrates, lawyers, court medical experts, and specialists in compensation for physical injury. Médecine et Droit provides: • rigorous and clear support for informative and educational matter • a tool for reflection and actualisation of knowledge • an essential link between doctors and lawyers. Médecine et Droit informs: • doctors on different aspects of law and regulations encountered in their profession • lawyers on the specific problems of the medical profession and important bio-ethical issues